These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 22781890)

  • 21. Vincristine-laden platelet transfusion for patients with refractory thrombocytopenia.
    Ganti AK; Landmark JD; Kessinger A; Smith LM; Tarantolo SR
    In Vivo; 2006; 20(4):559-63. PubMed ID: 16900790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
    Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.
    Gurevich-Shapiro A; Tzadok S; Rosenberg A; Inbal A; Bar-Natan M; Wolach O; Raanani P
    Acta Haematol; 2017; 137(4):183-190. PubMed ID: 28419992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of fresh platelet concentrate or lyophilized platelets in thrombocytopenic dogs with clinical signs of hemorrhage: a preliminary trial in 37 dogs.
    Davidow EB; Brainard B; Martin LG; Beal MW; Bode A; Ford MJ; Ramsey N; Fagella A; Jutkowitz A
    J Vet Emerg Crit Care (San Antonio); 2012 Feb; 22(1):116-25. PubMed ID: 23016747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.
    Murphy S; Snyder E; Cable R; Slichter SJ; Strauss RG; McCullough J; Lin JS; Corash L; Conlan MG;
    Transfusion; 2006 Jan; 46(1):24-33. PubMed ID: 16398727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin.
    Goodnough LT; Kuter DJ; McCullough J; Slichter SJ; DiPersio J; Romo J; Peterson R; Smith KJ; Raife T; Tomita D; Armstrong S
    Blood; 2001 Sep; 98(5):1346-51. PubMed ID: 11520781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
    Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
    Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
    Xu YH; Chen ZW; Ye XY; Lu S
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):716-9. PubMed ID: 19173920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective observational study of low thresholds for platelet transfusion in adult dengue patients.
    Thomas L; Kaidomar S; Kerob-Bauchet B; Moravie V; Brouste Y; King JP; Schmitt S; Besnier F; Abel S; Mehdaoui H; Plumelle Y; Najioullah F; Fonteau C; Richard P; Césaire R; Cabié A
    Transfusion; 2009 Jul; 49(7):1400-11. PubMed ID: 19320862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of transfusion of platelet concentrates obtained by manual pooling or by semiautomated pooling of buffy-coats: a retrospective analysis of count increment, corrected count increment and transfusion interval.
    Cid J; Ramiro L; Escoda L; Llorente A
    Vox Sang; 2009 Jan; 96(1):29-33. PubMed ID: 19121195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation.
    Briggs C; Hart D; Kunka S; Oguni S; Machin SJ
    Transfus Med; 2006 Apr; 16(2):101-9. PubMed ID: 16623916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
    Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
    Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bleeding prophylaxis in autologous bone marrow transplantation for solid tumors. Comparison of cryopreserved autologous and fresh allogeneic single-donor platelets.
    Mulder PO; Maas A; de Vries EG; Orie JL; Sleijfer DT; Smit Sibinga CT; Willemse PH; Mulder NH
    Haemostasis; 1989; 19(2):120-4. PubMed ID: 2659444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro thromboelastometric evaluation of the efficacy of frozen platelet transfusion.
    Pérez-Ferrer A; Navarro-Suay R; Viejo-Llorente A; Alcaide-Martín MJ; de Vicente-Sánchez J; Butta N; de Prádena Y Lobón JM; Povo-Castilla J
    Thromb Res; 2015 Aug; 136(2):348-53. PubMed ID: 26058942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical study on platelet engraftment by thrombopoietin in patients with hematological malignancies after allogeneic hematopoietic stem cell transplantation].
    Miao M; Wu DP; Cao XS; Dong WM; Wang B; Ou YJ; Li ZY; Li DP; Yang MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):362-5. PubMed ID: 22781792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Phase II clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia].
    Wang XY; Feng FY; Song ST; Wang HQ; Zhang MH; Liu J; Liu XY; Xu LG; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):373-6. PubMed ID: 16117903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immediate adverse reactions to platelet transfusions: whole blood derived versus apheresis platelets.
    Salam A; Hosain GM; Narvios A; Sazama K; Lichtiger B
    Mymensingh Med J; 2013 Jan; 22(1):143-7. PubMed ID: 23416822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
    Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
    Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.